JP2017537934A5 - - Google Patents

Download PDF

Info

Publication number
JP2017537934A5
JP2017537934A5 JP2017530302A JP2017530302A JP2017537934A5 JP 2017537934 A5 JP2017537934 A5 JP 2017537934A5 JP 2017530302 A JP2017530302 A JP 2017530302A JP 2017530302 A JP2017530302 A JP 2017530302A JP 2017537934 A5 JP2017537934 A5 JP 2017537934A5
Authority
JP
Japan
Prior art keywords
fibulin
fibroblast
keloid
cell
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017530302A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017537934A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2015/051187 external-priority patent/WO2016092542A1/en
Publication of JP2017537934A publication Critical patent/JP2017537934A/ja
Publication of JP2017537934A5 publication Critical patent/JP2017537934A5/ja
Pending legal-status Critical Current

Links

JP2017530302A 2014-12-07 2015-12-07 ケロイド瘢痕を処置するためのフィビュリン−５の使用 Pending JP2017537934A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462088607P 2014-12-07 2014-12-07
US62/088,607 2014-12-07
PCT/IL2015/051187 WO2016092542A1 (en) 2014-12-07 2015-12-07 Use of fibulin-5 for the treatment of keloid scars

Publications (2)

Publication Number Publication Date
JP2017537934A JP2017537934A (ja) 2017-12-21
JP2017537934A5 true JP2017537934A5 (enExample) 2019-01-24

Family

ID=56106831

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017530302A Pending JP2017537934A (ja) 2014-12-07 2015-12-07 ケロイド瘢痕を処置するためのフィビュリン−５の使用

Country Status (4)

Country Link
US (1) US20190030125A1 (enExample)
EP (1) EP3226886A4 (enExample)
JP (1) JP2017537934A (enExample)
WO (1) WO2016092542A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3312608B1 (en) * 2016-10-24 2019-10-02 Akribes Biomedical GmbH Methods for identifying a non-healing skin wound and for monitoring the healing of a skin wound
WO2018101449A1 (ja) * 2016-11-30 2018-06-07 株式会社資生堂 肌特性解析方法
CN111163784B (zh) * 2017-09-01 2024-07-26 黄玲惠 用于治疗蟹足肿的药物组合物及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0300810A2 (hu) * 2000-07-20 2003-08-28 M.G.V.S. Ltd. Mesterséges értranszplantátum, valamint ennek létrehozása és alkalmazása
CA2561495A1 (en) * 2004-03-29 2005-10-06 Kyoto University Truncated dance, dance complex and method of using these
EP1860182B1 (en) * 2005-02-07 2014-05-07 Kansai Medical University Method of regenerating elastic fiber with the use of dance or factor enhancing the expression thereof
US7943590B2 (en) * 2007-03-16 2011-05-17 Multi-Gene Vascular Systems Ltd. Compositions and methods for treating ophthalmic disorders
JP5560491B2 (ja) * 2007-12-07 2014-07-30 茂彦 鈴木 ケロイド及び肥厚性瘢痕根治治療剤
JP5839814B2 (ja) * 2010-03-17 2016-01-06 グンゼ株式会社 Ｄａｎｃｅタンパク質含有徐放基材及び該徐放基材の製造方法

Similar Documents

Publication Publication Date Title
WO2014027965A8 (en) Wound dressing nanomesh impregnated with human umbilical cord wharton's jelly stem cells
EP2181722A3 (en) Delayed gelation compositions and methods of use
AU2018256579A1 (en) Methods for preparing a skin graft
WO2010086848A3 (en) Wound dressings, methods and apparatus for making same and storage and use thereof
MX2019010385A (es) Dispositivos, metodos y composiciones utiles en la crio-conservacion, -almacenamiento, -transporte y aplicacion de celulas terapeuticas de mamiferos.
WO2012091952A3 (en) Median lobe retraction apparatus and method
WO2012037519A3 (en) Acceleration of wound healing by growth hormone releasing hormone and its agonists
BR112012030017A2 (pt) cateter-balão revestido com um agente antirrestenótico e um dispersante molecular de promoção de transporte
TN2012000067A1 (en) Oxazine derivatives and their use in the treatment of neurological disorders
MX354144B (es) Metodo, fabricacion y uso de productos medicos que liberan sustancia activa para mantener vasos sanguineos abiertos.
WO2012068515A3 (en) Compositions and methods for hair growth
MX2016009852A (es) Sistemas para el cuidado de la piel despues del procedimiento, composiciones y metodos de uso de los mismos.
NZ607306A (en) Compounds and methods for skin repair
MX340253B (es) Recubrimiento de aguja quirúrgica y métodos.
MX2013005995A (es) Composicion topica que promueve la melanina.
SG10201806020VA (en) Electroactive bioadhesive compositions
FR2958163B1 (fr) Preparation issue d'une culture in vitro de cellules dedifferencieres non elicitees d'arganier, leur utilisation pour le traitement du vieillissement cutane, de l'inflammation et de la cicatrisation, et leur obtention.
MY157534A (en) Composition for skin external application and functional food containing rose placenta tissue culture or extract thereof
JP2017530151A5 (enExample)
JP2017537934A5 (enExample)
WO2014110353A8 (en) Notch ligand bound biocompatible substrates and their use in bone formation
CA2899775C (en) Compositions and methods for pain relief without numbness
MX360157B (es) Uso de derivados de 2-carboxamida-cicloamino-urea en el tratamiento de enfermedades dependientes de egfr o de enfermedades que han adquirido resistencia a los agentes que tienen como objetivo los miembros de la familia egfr.
WO2014053906A8 (en) The application of stem cells in the orthodontic maxillary expansion
EP2898891A3 (en) Terminalia chebula and Terminalia bellerica extracts for inhibition of xanthine oxidase